In nondiabetic obese individuals, β-cell mass accretion maintains glucose homeostasis by balancing levels of circulating insulin and insulin resistance. Type 2 diabetes appears when these compensatory mechanisms fail. Deciphering the pathways controlling β-cell proliferation may help to identify therapeutic targets to expand β-cell mass and prevent or delay the onset of diabetes. Previously we demonstrated that the monounsaturated fatty-acid oleate potentiates glucose-induced rat β-cell proliferation.

Aim: To identify the transcriptional mechanisms underlying oleate-induced rat β-cell proliferation.

Methods: Rat islets were exposed to 16.7mM glucose (Glu) with or without 0.5 mM oleate (Glu+Ol) or palmitate (Glu+Pal) for 48h. Proliferation was assessed by flow cytometry (C-peptide staining and EdU incorporation). Single-cell cDNA libraries were generated using 10X Genomics technology and sequenced on the Illumina platform. Bioinformatic analyses were performed using Seurat package.

Results: β-cell proliferation was potentiated by Ol, but not Pal. Following single-cell RNA sequencing, UMAP plots revealed several β-cell sub-populations, including proliferating β-cells. A number of differences in gene expression were identified between groups in non-proliferating sub-populations. Among these, gene sets involved in ER-stress and β-cell differentiation were significantly up- and down-regulated, respectively, in response to Pal, but not Ol. Gene set enrichment analyses comparing proliferative vs. non-proliferative β-cells revealed an up-regulation of reactive oxygen species (ROS) and oxidoreductase activity-related pathways in both Glu and Glu+Ol groups. The antioxidant N-acetyl cysteine or the peroxiredoxin inhibitor Conoidin A inhibited Glu+Ol-induced β-cell proliferation.

Conclusion: Our results suggest the involvement of ROS signaling through a redox relay via peroxiredoxin activation in nutrient-induced β-cell proliferation.

Disclosure

A. Vivoli: None. J. Ghislain: None. A. Castell: None. A. Filali: None. R. M. Sladek: None. V. Poitout: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.